Effects of Althesin (Glaxo CT 1341) on coronary blood flow and myocardial metabolism in man.
D000136:Acid-Base Equilibrium / Q000187:drug effects; D000328:Adult; D000777:Anesthetics / Q000494:pharmacology*; D001769:Blood; D001786:Blood Glucose / Q000378:metabolism; D001794:Blood Pressure / Q000187:drug effects; D002200:Capillary Resistance / Q000187:drug effects; D002245:Carbon Dioxide / Q000097:blood; D002302:Cardiac Output / Q000187:drug effects; D003326:Coronary Circulation / Q000187:drug effects*; D004338:Drug Combinations; D004562:Electrocardiography; D004573:Electrolytes / Q000097:blood; D005230:Fatty Acids, Nonesterified / Q000097:blood; D006321:Heart / Q000187:drug effects*; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006863:Hydrogen-Ion Concentration; D006914:Hydroxysteroids / Q000494:pharmacology; D007773:Lactates / Q000097:blood; D008875:Middle Aged; D009206:Myocardium / Q000378:metabolism; D010100:Oxygen / Q000097:blood; D010101:Oxygen Consumption / Q000187:drug effects*; D011277:Pregnanediones / Q000494:pharmacology*; D011773:Pyruvates / Q000097:blood; D014655:Vascular Resistance / Q000187:drug effects
D000777:Anesthetics; D001786:Blood Glucose; D004338:Drug Combinations; D004573:Electrolytes; D005230:Fatty Acids, Nonesterified; D006914:Hydroxysteroids; D007773:Lactates; D011277:Pregnanediones; D011773:Pyruvates; D002245:Carbon Dioxide; D010100:Oxygen